Background: Adhesive capsulitis is a prevalent condition that leads to substantial impairment. Despite more than a century of medical intervention for this ailment, the precise understanding, identification, underlying causes, and most effective therapies remain mostly uncertain. Adhesive capsulitis is a prevalent condition that leads to substantial impairment. Despite more than a century of medical intervention for this ailment, the precise understanding, diagnosis, underlying causes, and most effective therapies remain largely uncertain. This analysis of the most current body of data emphasizes important areas for further investigation, specifically focusing on the growing significance of arthroscopic capsular release as a therapeutic approach. Conducting high-quality, sufficiently powered randomized controlled trials that compare the most prevalent therapies to a sham procedure would be the optimal approach to enhance the existing evidence base. Nevertheless, these investigations are challenging to design and get participants for. The level of discomfort experienced in extreme instances of frozen shoulder is so great that it may be deemed unethical to include a control group with no therapy as an option. Aim: To assess and compare the effectiveness of available treatment options for frozen shoulder to guide musculoskeletal practitioners and inform guidelines. Materials and method:A systematic review was conducted during June 2020 to April 2021 using the MeSH Terms) joint capsule release, capsular, capsular release, bursitis, bursitis, frozen, shoulder, frozen shoulder. Pubmed, Scopus, Embase and google scholar databases were also searched with the same search strategy and the references of selected journals were scanned to try to find more studies. Results: The early use of IA corticosteroid in patients with frozen shoulder of less than 1-year duration is associated with better outcomes. This treatment should be accompanied by a home exercise program to maximize the chance of recovery. Conclusion: Conservative management strategies, including physiotherapy, NSAIDs, corticosteroid injections, and hydrodilatation, form the backbone of initial treatment for frozen shoulder. These approaches aim to alleviate pain, restore range of motion, and improve shoulder function. For patients who do not respond to conservative measures, surgical interventions such as MUA, arthroscopic capsular release, and open capsular release offer effective solutions. Emerging therapies, including biologic agents and novel pharmacological innovations, hold promise for enhancing the treatment landscape of frozen shoulder. Future research should continue to explore these innovative approaches to improve patient outcomes and quality of life.